The purpose of this webinar is to enable participants to increase their knowledge of best practices for managing HIV treatment among pregnant patients.
Upon completion, participants will be able to:
List the basic tenets of managing antiretroviral therapy (ART) in a pregnant woman
State at least 3 topics providers should address prior to delivery with women living with HIV
Explain your approach to a woman who is not virally suppressed by 35 weeks gestation
Speaker to be provided by the National Clinician Consultation Center at the University of California, San Francisco
PSNA: The MidAtlantic AIDS Education and Training Center is an approved provider of continuing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This activity qualifies for 1.0 contact hours.
CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Pittsburgh School of Medicine and MidAtlantic AIDS Education and Training Center. The University of Pittsburgh School of Medicine accredited by the ACCME to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care profesionals are awarded 0.1 continuing education units (CEU's) which are equal to 1.0 contact hours.
CEU: The MidAtlantic AIDS Education and Training Center, Department of Infectious Diseases and Microbiology, University of Pittsburgh, awards Continuing Education Units to individuals who enroll in certain educational activities. This program is awarded 0.10 continuing education credits.
A variety of the listed populations will be discussed at this event.
A variety of the listed topics will be discussed at this event.
Prevention of perinatal or mother-to-child transmission